Results 191 to 200 of about 36,931 (245)

Correction: c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity

Frontiers in Immunology
Parham Jabbarzadeh Kaboli, Ghazaal Roozitalab, Reyhaneh Farghadani, Zoya Eskandarian, Abdessamad Zerrouqi   +4 more
doaj   +1 more source

Galectin-3 in AKI: Pathogenic Target, Diagnostic Biomarker, or Both? [PDF]

Int J Biol Sci
Gui Y, Zhou D.
europepmc   +1 more source

Multiplexed targeted mRNA profiling of alcohol-related liver disease reveals stage-specific dysregulation of signaling pathways. [PDF]

Mol Biol Rep
Rasic D, Thiele M, Andersen P, Krag A, Detlefsen S.   +4 more
europepmc   +1 more source

Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications. [PDF]

Curr Oncol
Narvel H, Ganiyani MA, Gulam Nabi A, Goyal A, Garje R, Srinivasan S, Ahmed H, Kilari D.   +7 more
europepmc   +1 more source

Photodynamic therapy with zinc phthalocyanine suppresses immune checkpoints in human melanoma cells. [PDF]

Lasers Med Sci
Doustvandi MA, Hajizadeh M, Mohammadnejad F, Karamali N, Yari AH, Nobari SA, Baradaran B.   +6 more
europepmc   +1 more source

Selective Nanobody-Derived Minibodies Targeting Galectin-1 and -7 Reveal Non-Redundant Glyco-Immune Functions and Therapeutic Potential in Triple-Negative Breast Cancer. [PDF]

J Med Chem
Nehmé R, Fortier M, Granger Joly de Boissel P, Caza F, Fronton F, Bourguignon L, Charpentier T, Fuselier C, Ferchiou S, D'Auteuil N, Gaboury L, Lamarre A, Chatenet D, St-Pierre Y.   +13 more
europepmc   +1 more source

Analysis of Galectin-3 in Differentiating Non-malignant and Malignant Nodular Thyroid Lesions. [PDF]

Cureus
J S, Es K, Srinivasan S.
europepmc   +1 more source

Galectin

Galectin
openaire